摘要
瑞舒伐他汀(rosuvastatin)是一种选择性HMG-Co A还原酶抑制剂,用于治疗高脂血症、高胆固醇血症及动脉硬化症等相关疾病。本文从瑞舒伐他汀原料及制剂、药理及临床研究方面综述瑞舒伐他汀研究进展。
Rosuvastatin is a selective inhibitor of HMG-Co A reductase, which is used for treatment of hyperlipidemia, hypercholesterolemia and arteriosclerosis. The research progress on raw materials and preparations, and pharmacological and clinical research of rosuvastatin are reviewed in this paper.
作者
胡建强
臧恒昌
HU Jian-qiang;ZANG Heng-chang(School of Pharmaceutical Sciences,Shandong University,Yinan 250012,China;Shandong Longom Pharmaceutical Co.,Ltd.,Dezhou 251100,China)
出处
《食品与药品》
CAS
2018年第4期321-324,共4页
Food and Drug
关键词
瑞舒伐他汀
原料
制剂
临床研究
rosuvastatin
raw medicine
preparation
clinicaltrial
